HK1036010A1 - Fizzy formulations - Google Patents

Fizzy formulations

Info

Publication number
HK1036010A1
HK1036010A1 HK01106643A HK01106643A HK1036010A1 HK 1036010 A1 HK1036010 A1 HK 1036010A1 HK 01106643 A HK01106643 A HK 01106643A HK 01106643 A HK01106643 A HK 01106643A HK 1036010 A1 HK1036010 A1 HK 1036010A1
Authority
HK
Hong Kong
Prior art keywords
fizzy
formulations
fizzy formulations
Prior art date
Application number
HK01106643A
Other languages
English (en)
Inventor
Wolfram Tritthart
Maria Andre Piskernig
Gottfried Kolbl
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of HK1036010A1 publication Critical patent/HK1036010A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
HK01106643A 1998-03-31 2001-09-20 Fizzy formulations HK1036010A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814257A DE19814257A1 (de) 1998-03-31 1998-03-31 Brauseformulierungen
PCT/DE1999/000798 WO1999049842A1 (de) 1998-03-31 1999-03-20 Brauseformulierungen

Publications (1)

Publication Number Publication Date
HK1036010A1 true HK1036010A1 (en) 2001-12-21

Family

ID=7863015

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01106643A HK1036010A1 (en) 1998-03-31 2001-09-20 Fizzy formulations

Country Status (29)

Country Link
US (1) US6242002B1 (ru)
EP (1) EP1067905B1 (ru)
JP (1) JP4469494B2 (ru)
KR (1) KR100607395B1 (ru)
CN (1) CN1138529C (ru)
AR (1) AR018829A1 (ru)
AT (1) ATE224703T1 (ru)
AU (1) AU753194B2 (ru)
BG (1) BG65043B1 (ru)
BR (1) BR9909266A (ru)
CA (1) CA2326502C (ru)
CZ (1) CZ300705B6 (ru)
DE (2) DE19814257A1 (ru)
DK (1) DK1067905T3 (ru)
ES (1) ES2183555T3 (ru)
HK (1) HK1036010A1 (ru)
HU (1) HU229793B1 (ru)
IL (1) IL138605A (ru)
NO (1) NO329143B1 (ru)
NZ (1) NZ506989A (ru)
PL (1) PL192049B1 (ru)
PT (1) PT1067905E (ru)
RU (1) RU2221554C2 (ru)
SK (1) SK284477B6 (ru)
TR (1) TR200002812T2 (ru)
TW (1) TW580398B (ru)
UA (1) UA66847C2 (ru)
WO (1) WO1999049842A1 (ru)
ZA (1) ZA200005133B (ru)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
AU2004242477B2 (en) * 1999-03-26 2007-04-19 Cima Labs Inc. Sublingual buccal effervescent
AU2007203233B2 (en) * 1999-03-26 2010-02-25 Cima Labs Inc. Sublingual buccal effervescent
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US20040175456A1 (en) * 2003-03-06 2004-09-09 Lauren Keilbach Tablets for feeding fish and methods of making tablets for feeding fish
US20040191298A1 (en) * 2003-03-26 2004-09-30 Fredrik Nicklasson New formulations and use thereof
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
CA2548915C (en) 2003-12-31 2012-10-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7033511B2 (en) 2004-01-20 2006-04-25 A-Dec, Inc. Sustained water treatment in dental equipment
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP1938842A4 (en) * 2005-09-01 2013-01-09 Eisai R&D Man Co Ltd METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION COMPRISING IMPROVED CRASHING CHARACTERISTICS
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP1954298A4 (en) * 2005-11-28 2012-10-31 Imaginot Pty Ltd DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION
PT2361081T (pt) * 2008-10-14 2016-09-05 Mcneil Ab Forma de dosagem intra-oral multiporção e seu uso
KR101233352B1 (ko) * 2009-04-22 2013-02-25 (주)비씨월드제약 유전자 재조합 과립구-대식세포 집락 촉진인자를 함유하는 정제
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
ES2705950T3 (es) 2011-06-03 2019-03-27 Eisai R&D Man Co Ltd Biomarcadores para predecir y valorar la capacidad de respuesta de sujetos con cáncer de tiroides y de riñón a compuestos de lenvatinib
CA2863613C (en) 2012-02-01 2020-10-27 Intercontinental Great Brands Llc Low calorie drink tablet
CN104755463A (zh) 2012-12-21 2015-07-01 卫材R&D管理有限公司 非晶态形式的喹啉衍生物及其生产方法
MX368099B (es) 2013-05-14 2019-09-19 Eisai R&D Man Co Ltd Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
JO3783B1 (ar) 2014-08-28 2021-01-31 Eisai R&D Man Co Ltd مشتق كوينولين عالي النقاء وطريقة لإنتاجه
DK3263106T3 (da) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
CN107801379B (zh) 2015-06-16 2021-05-25 卫材R&D管理有限公司 抗癌剂
CN109303334B (zh) * 2018-10-17 2021-04-13 汤臣倍健股份有限公司 一种口腔微泡腾片及其制备方法
EP3799864B1 (en) * 2019-10-02 2023-03-01 Intas Pharmaceuticals Limited Essentially sodium-free effervescent solid pharmaceutical compositions
WO2021239541A1 (en) * 2020-05-28 2021-12-02 Unilever Ip Holdings B.V. Tablet

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
WO1993000886A1 (de) 1991-07-01 1993-01-21 Gerhard Gergely Reaktionsdotierte brausesysteme
ATE122228T1 (de) 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
PT647137E (pt) 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
DE4225730C2 (de) 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
EP0683668A4 (en) * 1993-01-27 1997-12-29 Affymax Tech Nv PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
US5287394A (en) 1993-03-22 1994-02-15 Advanced Micro Devices, Inc. Fast counter with uniform delay structures
SE9301112D0 (sv) 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition
ES2091654T3 (es) * 1993-04-15 1996-11-01 Gergely Gerhard Sistema efervescente que contiene un ingrediente activo farmaceutico sensible a alcalis y/o metales, y procedimiento para su produccion.
JP3489831B2 (ja) 1993-04-20 2004-01-26 ヘクサル・アクチエンゲゼルシャフト 活性成分パッチ
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
ATE173614T1 (de) 1993-09-09 1998-12-15 Gerhard Gergely Brausegranulat und verfahren zu seiner herstellung
ATE162110T1 (de) 1993-11-12 1998-01-15 Gregely Gerhard Verfahren zum herstellen von granulat
US5484608A (en) 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
HU223475B1 (hu) 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
DE29500718U1 (de) * 1995-01-18 1995-04-06 Rau Reinhard Element einer Zeltplane zum Aufbau von kohten- und jurtenähnlichen Zeltaufbauten
DK0866691T4 (da) 1995-11-06 2005-06-06 Somerset Pharmaceuticals Inc Medikamenter til sublingual og bukkal administration af selegilin

Also Published As

Publication number Publication date
AU4029499A (en) 1999-10-18
CA2326502C (en) 2008-08-05
US6242002B1 (en) 2001-06-05
IL138605A0 (en) 2001-10-31
NO329143B1 (no) 2010-08-30
ES2183555T3 (es) 2003-03-16
CA2326502A1 (en) 1999-10-07
WO1999049842A1 (de) 1999-10-07
UA66847C2 (ru) 2004-06-15
CN1138529C (zh) 2004-02-18
PL343260A1 (en) 2001-07-30
HU229793B1 (en) 2014-07-28
DE19814257A1 (de) 1999-10-07
CZ20003482A3 (en) 2001-05-16
CZ300705B6 (cs) 2009-07-22
HUP0101427A3 (en) 2001-12-28
CN1295463A (zh) 2001-05-16
BG104841A (en) 2001-07-31
DE59902843D1 (de) 2002-10-31
BR9909266A (pt) 2000-11-21
SK14322000A3 (sk) 2001-07-10
TW580398B (en) 2004-03-21
DK1067905T3 (da) 2003-02-03
KR100607395B1 (ko) 2006-08-02
ATE224703T1 (de) 2002-10-15
NO20004721L (no) 2000-09-21
EP1067905B1 (de) 2002-09-25
PL192049B1 (pl) 2006-08-31
RU2221554C2 (ru) 2004-01-20
BG65043B1 (bg) 2007-01-31
IL138605A (en) 2005-11-20
AR018829A1 (es) 2001-12-12
SK284477B6 (sk) 2005-04-01
AU753194B2 (en) 2002-10-10
PT1067905E (pt) 2003-02-28
EP1067905A1 (de) 2001-01-17
HUP0101427A2 (hu) 2001-08-28
KR20010042317A (ko) 2001-05-25
NZ506989A (en) 2002-09-27
JP4469494B2 (ja) 2010-05-26
ZA200005133B (en) 2001-02-28
TR200002812T2 (tr) 2001-01-22
JP2002509872A (ja) 2002-04-02
NO20004721D0 (no) 2000-09-21

Similar Documents

Publication Publication Date Title
HK1036010A1 (en) Fizzy formulations
PL343021A1 (en) Formulations
GB9715751D0 (en) Formulations
EP1113799A4 (en) PROTEIN-BASED PREPARATION
IL139541A0 (en) Novel particulate formulations
HUP0104573A3 (en) Agrochemical formulations
PL346423A1 (en) Microcapsule formulations
PL346414A1 (en) Microcapsule formulations
GB9806312D0 (en) Novel formulations
GB9810180D0 (en) Novel formulation
HU9900892D0 (en) Enclosed multiple-biofilter
GB9815002D0 (en) Formulations
GB9815001D0 (en) Formulations
GB9816697D0 (en) Liquid formulations
GB9810181D0 (en) Novel formulations
SI1067905T1 (en) Fizzy formulations
TW407677U (en) Form
GB9814483D0 (en) Challenge
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
GB9823645D0 (en) Formulation
SI1468689T1 (sl) Pripravek 2-metil-tieno-benzodiazepina
GB9703100D0 (en) Formulations
GB9703099D0 (en) Formulations
GB9704521D0 (en) Formulations

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080320